Cargando…
PPI Long Term Use: Risk of Neurological Adverse Events?
The purpose of this review study is to reveal a potential threat of one type of such widely used and freely distributed drugs, which are proton pump inhibitors that might be the cause of the onset of both dementia and depression. The authors performed a literature review of available studies on the...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331532/ https://www.ncbi.nlm.nih.gov/pubmed/30671013 http://dx.doi.org/10.3389/fneur.2018.01142 |
_version_ | 1783387152733700096 |
---|---|
author | Novotny, Michal Klimova, Blanka Valis, Martin |
author_facet | Novotny, Michal Klimova, Blanka Valis, Martin |
author_sort | Novotny, Michal |
collection | PubMed |
description | The purpose of this review study is to reveal a potential threat of one type of such widely used and freely distributed drugs, which are proton pump inhibitors that might be the cause of the onset of both dementia and depression. The authors performed a literature review of available studies on the research topic describing the adverse effect of proton pum inhibitors (PPIs) (omeprazole, esomeprazole, lansoprazole, dexlansoprazole, rabeprazole, pantoprazole, dexrabeprazole, ilaprazole). For a long time, PPIs were considered to be completely safe drug substances for both short and long-term use. In recent years, there have been a few contradictory studis of absolute safety, especially in patients, who have long been using PPIs. At this time when depression and dementia are rising in the population, this is a very worrying fact that needs to be highlighted, and which needs to be carefully studied and evaluated, ideally trying to prevent it. The findings of most research studies described in this review indicate that there is a direct association between the onset of dementia and depression on one side and the long-term use of PPIs on the other. |
format | Online Article Text |
id | pubmed-6331532 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-63315322019-01-22 PPI Long Term Use: Risk of Neurological Adverse Events? Novotny, Michal Klimova, Blanka Valis, Martin Front Neurol Neurology The purpose of this review study is to reveal a potential threat of one type of such widely used and freely distributed drugs, which are proton pump inhibitors that might be the cause of the onset of both dementia and depression. The authors performed a literature review of available studies on the research topic describing the adverse effect of proton pum inhibitors (PPIs) (omeprazole, esomeprazole, lansoprazole, dexlansoprazole, rabeprazole, pantoprazole, dexrabeprazole, ilaprazole). For a long time, PPIs were considered to be completely safe drug substances for both short and long-term use. In recent years, there have been a few contradictory studis of absolute safety, especially in patients, who have long been using PPIs. At this time when depression and dementia are rising in the population, this is a very worrying fact that needs to be highlighted, and which needs to be carefully studied and evaluated, ideally trying to prevent it. The findings of most research studies described in this review indicate that there is a direct association between the onset of dementia and depression on one side and the long-term use of PPIs on the other. Frontiers Media S.A. 2019-01-08 /pmc/articles/PMC6331532/ /pubmed/30671013 http://dx.doi.org/10.3389/fneur.2018.01142 Text en Copyright © 2019 Novotny, Klimova and Valis. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neurology Novotny, Michal Klimova, Blanka Valis, Martin PPI Long Term Use: Risk of Neurological Adverse Events? |
title | PPI Long Term Use: Risk of Neurological Adverse Events? |
title_full | PPI Long Term Use: Risk of Neurological Adverse Events? |
title_fullStr | PPI Long Term Use: Risk of Neurological Adverse Events? |
title_full_unstemmed | PPI Long Term Use: Risk of Neurological Adverse Events? |
title_short | PPI Long Term Use: Risk of Neurological Adverse Events? |
title_sort | ppi long term use: risk of neurological adverse events? |
topic | Neurology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331532/ https://www.ncbi.nlm.nih.gov/pubmed/30671013 http://dx.doi.org/10.3389/fneur.2018.01142 |
work_keys_str_mv | AT novotnymichal ppilongtermuseriskofneurologicaladverseevents AT klimovablanka ppilongtermuseriskofneurologicaladverseevents AT valismartin ppilongtermuseriskofneurologicaladverseevents |